ADHD Research and News

Spravato Approved for Treatment-Resistant Depression

Spravato, the esketamine nasal spray, was approved by the FDA for treatment-resistant depression as a...

The Make America Healthy Again Commission created by executive order last week and chaired by new...

Stimulant medication may improve deficits in empathy, as well as narcissistic personality traits, in...

ADHD symptoms seem to disappear, return, worsen, and improve over the lifetime for many people. Here,...

Autistic children with ADHD are at higher risk for cognitive disengagement syndrome (CDS) than are...

The life expectancy for a woman with ADHD is 8.6 years shorter than it is for her neurotypical peers,...

Learning disabilities and conduct disorders are more common among men with ADHD, while women with...

Pregnant women with ADHD who used methylphenidate or atomoxetine were not at higher risk for...

New research exploring the diverse landscape of sensory processing differences shows a prevalence of...

This year, we learned that ADHD misdiagnosis and inadequate treatment in adulthood stem from poor...

Exposure to exhaust from leaded gasoline is tied to millions of cases of mental health disorders...

The Department of Defense has removed waiver requirements and lowered treatment hurdles for 51...